Tuberculosis: latest advances and challenges in patient management

Lunchtime session
Chairs: G. Bothamley (London, United Kingdom), E. Grainger (London, United Kingdom)
Aims: to provide an overview of the latest treatments and cutting-edge research; to discuss current challenges in patient diagnostics and management; to discuss updated World Health Organization guideline recommendations for multidrug-resistant tuberculosis based on recent findings such as an individual patient data meta-analysis published in The Lancet (2018; 392: 821-34); to focus on both adult and paediatric cases.

Management and treatment of multidrug-resistant tuberculosis C. Lange (Borstel, Germany)
Challenges in the prevention, diagnosis, and treatment of tuberculosis in children J. Furin (Strongsville, United States of America)
Latest insights and challenges in tuberculosis vaccine development H. Mcshane (Oxford (Oxfordshire), United Kingdom)
Randomised controlled double blind dose-escalation infant trial of the live-attenuated Mycobacterium tuberculosis vaccine MTBVAC M. Tameris (Cape Town, South Africa)